Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-87.58	13.93	112.13
Graham Fair Price	54.96	1.75	1.13
PEG	-54.87	0.31	-0.69
Price/Book	-2.17	0.13	0.14
Price/Cash Flow	-98.33	5.20	310.84
Prices/Earnings	-51.09	37.42	76.50
Price/Sales	-64.10	1.38	3.84
Price/FCF	-98.33	5.20	310.84
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-44.76	0.55	1.00
Operating Margin	400.48	0.22	0.04
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	0.01	1234.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	1.09	-0.51	115.54
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.92	12.64	1271.08
EPS QOQ	1.11	1.20	8.37
FCF QOQ	-0.98	57.47	5739.70
Revenue QOQ	-0.52	1.72	234.80
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	410.29	100.00
Days Sales Outstanding (DSO)	0.00	200.76	100.00
Inventory Turnover	0.00	0.22	100.00
Debt/Capitalization	0.21	0.36	68.52
Quick Ratio	5.29	8.47	60.20
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	11.31	12.39	9.57
Cash	3.82	6.03	58.00
Capex	-0.02	-0.03	-14.18
Free Cash Flow	< 0.005	0.32	6306.61
Revenue	0.40	1.19	198.57
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	5.29	4.08	-22.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-106.44	8.84	-91.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating